Table 4.

Analysis of 42 brain tumor cases from St George's Hospital

Sample ID	Sex	Age	KAL1 level by microarray	KAL1 level by qRT-PCR	Type of tumor
524	M	34	9.57	7.17×10−4	Glioblastoma (WHO grade IV)
427	M	59	11.79	2.98×10−4	Glioblastoma (WHO grade IV)
433	F	70	11.88	1.77×10−4	Glioblastoma (WHO grade IV)
409	M	57	11.13	2.67×10−5	Glioblastoma (WHO grade IV)
426	F	61	10.97	8.31×10−5	Glioblastoma (WHO grade IV)
417	M	56	11.48	4.87×10−5	Glioblastoma (WHO grade IV)
463	F	65	9.88	4.15×10−5	Glioblastoma (WHO grade IV)
018	M	79	10.14	NA	Glioblastoma (WHO grade IV)
461	M	16	11.26	NA	Glioblastoma (WHO grade IV)
369	F	65	10.42	NA	Glioblastoma (WHO grade IV)
460	F	58	9.62	NA	Glioblastoma (WHO grade IV)
366	M	40	9.96	3.23×10−4	Anaplastic ependyoma (WHO grade III)
140	F	27	11.08	NA	Anaplastic astrocytoma (WHO grade III)
079	F	40	12.50	NA	Astrocytoma (WHO grade II)
403	M	19	10.28	NA	Gemistocytic astrocytoma (WHO grade II)
360	M	49	3.94	7.73×10−5	Meningioma (WHO grade I)
501	F	71	8.95	7.72×10−5	Meningioma (WHO grade I)
549	F	66	6.55	5.96×10−5	Meningioma (WHO grade I)
048	F	78	5.73	3.39×10−5	Meningioma (WHO grade I)
521	F	88	7.77	3.28×10−5	Meningioma (WHO grade I)
514	F	46	7.56	2.74×10−5	Meningioma (WHO grade I)
169	M	66	8.00	1.90×10−5	Meningioma (WHO grade I)
167	F	35	6.99	9.98×10−6	Meningioma (WHO grade I)
456	M	52	7.08	4.14×10−6	Meningioma (WHO grade I)
384	M	49	5.35	3.89×10−6	Meningioma (WHO grade I)
476	F	65	7.57	0 (non-detected)	Meningioma (WHO grade I)
455	F	60	8.89	NA	Meningioma (WHO grade I)
367	F	37	3.92	NA	Meningioma (WHO grade I)
394	F	62	7.23	NA	Meningioma (WHO grade I)
502	M	72	3.18	NA	Meningioma (WHO grade I)
075	M	20	11.34	NA	Pilocytic astrocytoma (WHO grade I)
537	F	71	6.76	2.64×10−5	Haemangioblastoma (WHO grade I)
449	M	70	6.10	2.68×10−4	Metastatic adenocarcinoma
408	M	67	4.66	4.64×10−5	Metastatic adenocarcinoma
210	F	69	7.91	1.44×10−5	Metastatic adenocarcinoma
153	F	58	9.91	4.20×10−5	Metastatic adenocarcinoma
536	M	73	5.33	1.43×10−5	Metastatic adenocarcinoma
166	F	56	6.14	NA	Metastatic adenocarcinoma
475	M	60	8.13	NA	Metastatic adenocarcinoma
398	F	73	8.78	NA	Metastatic adenocarcinoma
211	F	65	9.22	NA	Metastatic adenocarcinoma
438	M	61	6.99	NA	Metastatic large cell carcinoma

The patients, types of tumors, and KAL1 expression levels assessed by microarray and qRT-PCR are shown. KAL1 mRNA level determined by qRT-PCR is indicated as the concentration ratio normalized to β-actin (shown in Fig. 1); NA, not determined due to limited tissue availability.